Clinical outcome using the Q300™ device in a reproductive laboratory environment: an open-label, non-controlled and non-randomized study.

Reprod Biol Endocrinol · 2025 · PMC12150528 · PMID 40495170

Europe PMC DOI

hedged sentences

0.0560

closest p · 1.1× alpha

0.1600

boldest claim

The sentences

a favorable trendp = 0.056so close (0.05 < p ≤ 0.1)

The blastocyst development rate demonstrated a favorable trend in the Q300TM group (54.3%) compared to the control group (43.2%), though this difference was not statistically significant ( p = 0.056).

also in 466 other papers

did not reach statistical significancep = 0.16not close (p > 0.1)

Similarly, the rate of good-quality blastocyst development was slightly higher in the Q300TM group (36.9%) versus the control group (31.5%) (Vienna consensus competency: ≥ 30%), but this difference did not reach statistical significance ( p = 0.16).

also in 33,519 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.